Pharmacological disease models
Small molecules and excitotoxic agents can be used to pharmacologically induce disease models such as epilepsy, Parkinson's Disease, catalepsy, Schizophrenia, pain and diabetes models. Researchers can save up to 50% on excitotoxic agents - they are up to half the price of other suppliers.
Recombinant human NT-3 protein (HB8373)
Description:Neurotrophin involved in neuron development, survival and differentiation
- Description:
Multifunctional protein with neurotrophic, anti-angiogenic and anti-tumorigenic properties
Recombinant human ProNGF protein (HB9354)
Description:Pro-form of the nerve growth factor (NGF) neurotrophin
Recombinant mouse beta-NGF protein (HB9755)
Description:Recombinant mouse neurotrophic factor related to BDNF, NT-3 and NT-4
Recombinant mouse MANF protein (HB6565)
Description:Neurotrophic factor with neuroprotective effects
Remdesivir (HB9521)
Description:Adenosine triphosphate analog with broad-spectrum antiviral activity
Purity:>98%
RepSox (HB3301)
Description:Potent, selective TGF-βRI inhibitor. Enhances cellular reprogramming efficiency.
Purity:>99%